Swiss National Bank Alpine Immune Sciences, Inc. Transaction History

Swiss National Bank

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$17.75 - $41.6 $111,825 - $262,080	6,300 Added 11.01%	63,500 $2.52 Million
Q4 2023 Feb 06, 2024	BUY	$8.54 - $20.22 $128,099 - $303,300	15,000 Added 35.55%	57,200 $1.09 Million
Q3 2023 Nov 08, 2023	BUY	$10.13 - $13.98 $427,486 - $589,956	42,200 New	42,200 $483,000

56.2K

Ticker ALPN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,006,700
Description
Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

Stay updated on Swiss National Bank with notifications on news.